Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT01864525

Effects of Octanoic Acid for Treatment of Essential Voice Tremor

Sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD)

Conditions Essential Tremor of Voice Essential Voice Tremor Vocal Tremor Voice Tremor

Interventions Inactive capsule Octanoic acid

Updated 8 times since 2017 Last updated: Jul 20, 2018 Started: Jul 31, 2013 Primary completion: Dec 22, 2016 Completion: Mar 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Essential Tremor of Voice and Essential Voice Tremor, this trial is completed. The trial is conducted by National Institute on Deafness and Other Communication Disorders (NIDCD) and has accumulated 8 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Sep 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Sep 2018 [monthly]

Completed PHASE1_PHASE2

▶ Show 3 earlier versions

May 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

Status: Recruiting → Completed
Feb 2017 — May 2017 [monthly]

Recruiting PHASE1_PHASE2
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE1_PHASE2

First recorded

Jul 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Deafness and Other Communication Disorders (NIDCD)
Syracuse University

Data source: Syracuse University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Syracuse, United States